Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring

por Kawaguchi, Yuji, Sawa, Jun, Kumeda, Yasuro
Publicado 2020

Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open‐label, cross‐over study using continuous glucose monitorin...

por Kawaguchi, Yuji, Sawa, Jun, Sakuma, Noriko, Kumeda, Yasuro
Publicado 2018

Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec

por Kawaguchi, Yuji, Sawa, Jun, Hamai, Chie, Kumeda, Yasuro
Publicado 2019

Comparison of the efficacy and safety of insulin degludec/aspart (twice‐daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal–bolus therapy)

por Kawaguchi, Yuji, Sawa, Jun, Hamai, Chie, Nishimura, Yuri, Kumeda, Yasuro
Publicado 2019

Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 di...

por Kawaguchi, Yuji, Miyamoto, Shoko, Hajika, Yuriko, Ashida, Narumi, Masumoto, Koji, Sawa, Jun, Hamazaki, Kenji, Kumeda, Yasuro
Publicado 2021

Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM

por Kawaguchi, Yuji, Miyamoto, Shoko, Hajika, Yuriko, Ashida, Narumi, Hirota, Tomoe, Masumoto, Koji, Sawa, Jun, Hamazaki, Kenji, Kumeda, Yasuro
Publicado 2022